Compare DERM & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | III |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | 1500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.9M | 193.7M |
| IPO Year | 2021 | 2006 |
| Metric | DERM | III |
|---|---|---|
| Price | $6.68 | $4.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $12.67 | $5.50 |
| AVG Volume (30 Days) | ★ 356.1K | 256.6K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.46% |
| EPS Growth | 34.72 | ★ 216.67 |
| EPS | N/A | ★ 0.05 |
| Revenue | $61,858,000.00 | ★ $192,745,000.00 |
| Revenue This Year | $39.72 | $3.85 |
| Revenue Next Year | $63.24 | $4.34 |
| P/E Ratio | ★ N/A | $81.20 |
| Revenue Growth | ★ 10.20 | 4.51 |
| 52 Week Low | $4.31 | $3.74 |
| 52 Week High | $9.56 | $6.45 |
| Indicator | DERM | III |
|---|---|---|
| Relative Strength Index (RSI) | 53.44 | 45.69 |
| Support Level | $5.80 | $3.88 |
| Resistance Level | $8.23 | $4.37 |
| Average True Range (ATR) | 0.47 | 0.14 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 56.00 | 57.89 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.